Influence of initial large dose on subsequent uptake of therapeutic radioiodine in thyroid cancer patients

International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology
R K JeevanramR D Ganatra

Abstract

Fifty-two patients with differentiated thyroid cancer, following thyroidectomy were studied by administering a quantity of up to 5 mCi of [131I]sodium iodide. In most of these patients, radioiodine uptake values obtained with the subsequent therapeutic dose were markedly lower than those observed with the initial doses. This observation was verified in seven of the patients with differentiated thyroid cancer, by measuring the radioiodine uptake with a second dose of 4.5 mCi of [131I]sodium iodide. Calculations showed that the major etiology was probably therapeutic irradiation of the thyroid by the first dose.

Citations

Jan 5, 2008·European Journal of Nuclear Medicine and Molecular Imaging·Ha T T PhanThera P Links
Jul 11, 2001·Endocrinology and Metabolism Clinics of North America·B R Haugen, E C Lin
Sep 13, 2002·Thyroid : Official Journal of the American Thyroid Association·Wellington Hung, Nicholas J Sarlis
Jun 14, 2003·Thyroid : Official Journal of the American Thyroid Association·Lilah F MorrisGlenn D Braunstein
Mar 28, 2002·Cancer Biotherapy & Radiopharmaceuticals·James C Sisson
Jan 1, 1994·Thyroid : Official Journal of the American Thyroid Association·H M ParkA Manatunga
Apr 1, 1997·Thyroid : Official Journal of the American Thyroid Association·H R MaxonR C Samaratunga
Apr 1, 1997·Thyroid : Official Journal of the American Thyroid Association·H M ParkX H Zhou
Apr 17, 1998·Thyroid : Official Journal of the American Thyroid Association·J C SissonS A Spaulding
Dec 17, 2005·Thyroid : Official Journal of the American Thyroid Association·Rafał CzepczyńskiJerzy Sowiński
Mar 3, 1998·Clinical Nuclear Medicine·C H Kao
Jan 24, 2002·Clinical Nuclear Medicine·Stephen K Gerard, Ralph R Cavalieri
Dec 3, 2002·Health Physics·Marvin I Friedman, Munir Ghesani
Feb 24, 2001·Nuclear Medicine Communications·M DietleinH Schicha
Jul 8, 2005·Nuclear Medicine Communications·Mario Medvedec
Jan 13, 2006·Nuclear Medicine Communications·Nidhal AliKeith E Britton
Apr 14, 2005·Clinical Nuclear Medicine·Herbert A KleinLois J Worthy
Apr 24, 2001·European Journal of Nuclear Medicine·M Medvedec
Mar 1, 2001·European Journal of Nuclear Medicine·O Sabri
Jul 2, 2015·International Journal of Molecular Sciences·Zbigniew AdamczewskiAndrzej Lewiński
Nov 20, 2015·EJNMMI Research·Stephan WalrandFrançois Jamar
Sep 10, 2005·Seminars in Nuclear Medicine·Charles M IntenzoDavid M Capuzzi
Jun 30, 2001·Seminars in Nuclear Medicine·Y Krausz
Jan 1, 1989·Seminars in Nuclear Medicine·P B ZanzonicoA Strauss
Jun 12, 2010·Clinical Oncology : a Journal of the Royal College of Radiologists·S E M Clarke
Jul 27, 2001·Best Practice & Research. Clinical Endocrinology & Metabolism·V J Lewington, S E Clarke
Feb 22, 2017·PloS One·Nils RudqvistEva Forssell-Aronsson
Nov 28, 2009·Arquivos brasileiros de endocrinologia e metabologia·Fabián PitoiaHugo Niepomniszcze
Mar 18, 2006·Arquivos brasileiros de endocrinologia e metabologia·Pedro Weslley S RosárioSaulo Purisch
Nov 23, 2006·Acta Oncologica·Gertrud Berg
Aug 21, 2004·Nuclear Medicine Communications·Judy E Kalinyak, I Ross McDougall
Aug 15, 2001·The Journal of Clinical Endocrinology and Metabolism·L F MorrisG D Braunstein
Mar 20, 1999·The Journal of Clinical Endocrinology and Metabolism·S S KoongJ Robbins
Jul 12, 2020·Journal of Pediatric Endocrinology & Metabolism : JPEM·Praveen KumarChandrasekhar Bal
Jan 2, 2019·Endocrine·Christian HappelFrank Grünwald
Mar 27, 2019·Clinical and Translational Imaging : Reviews in Nuclear Medicine and Molecular Imaging·Anca M Avram, Yuni K Dewaraja
Jun 16, 2009·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Charlotta LundhEva Forssell-Aronsson
Mar 4, 2020·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Kevin J DonohoeJason A Wexler

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved